Biofrontera Inc. (BFRI)
NASDAQ: BFRI
· Real-Time Price · USD
0.70
0.01 (0.73%)
At close: May 12, 2025, 10:03 AM
Biofrontera Revenue Breakdown
Period Ending | Dec 31, 2023 | Dec 31, 2022 |
---|---|---|
Government and Payor Rebates Revenue | 310K | 675K |
Government and Payor Rebates Revenue Growth | -54.07% | n/a |
Prompt Pay Discounts Revenue | 6K | 264K |
Prompt Pay Discounts Revenue Growth | -97.73% | n/a |
Returns Revenue | 52K | 67K |
Returns Revenue Growth | -22.39% | n/a |
Co-pay Assistance Program Revenue | 165K | 53K |
Co-pay Assistance Program Revenue Growth | +211.32% | n/a |
Operating Expense Breakdown
Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General, and Administrative Revenue | 8.17M | 8.43M | 7.95M | 9.25M | 8.77M | 8.62M | 11.55M | 9.83M | 10.21M | 7.94M | 10.02M | 7.71M | 9.28M | 17.25M | 5.75M | 4.92M | 4.16M | 4.3M | 3.67M | 5.98M |
Selling, General, and Administrative Revenue Growth | -3.01% | +6.01% | -14.09% | +5.53% | +1.69% | -25.36% | +17.51% | -3.73% | +28.63% | -20.76% | +29.88% | -16.88% | -46.22% | +200.10% | +16.78% | +18.23% | -3.23% | +17.25% | -38.68% | n/a |
Research and Development Revenue | 782K | 669K | 621K | 17K | 33K | 33K | 11K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Research and Development Revenue Growth | +16.89% | +7.73% | +3552.94% | -48.48% | 0.00% | +200.00% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |